2016 -- S 2356 | |
======== | |
LC004564 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2016 | |
____________ | |
A N A C T | |
RELATING TO HEALTH AND SAFETY -- INSURANCE--MENTAL ILLNESS AND | |
SUBSTANCE ABUSE | |
| |
Introduced By: Senators Miller, Jabour, Crowley, Goodwin, and Satchell | |
Date Introduced: February 10, 2016 | |
Referred To: Senate Health & Human Services | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Section 23-17.26-3 of the General Laws in Chapter 23-17.26 entitled |
2 | "Comprehensive Discharge Planning" is hereby amended to read as follows: |
3 | 23-17.26-3. Comprehensive discharge planning. -- (a) On or before July 1, 2015 2016, |
4 | each hospital operating in the State of Rhode Island shall submit to the director: |
5 | (1) Evidence of participation in a high-quality comprehensive discharge planning and |
6 | transitions improvement project operated by a nonprofit organization in this state; or |
7 | (2) A plan for the provision of comprehensive discharge planning and information to be |
8 | shared with patients transitioning from the hospitals care. Such plan shall contain the adoption of |
9 | evidence-based practices including, but not limited to: |
10 | (i) Providing in-hospital education prior to discharge; |
11 | (ii) Ensuring patient involvement such that, at discharge, patients and caregivers |
12 | understand the patient's conditions and medications and have a point of contact for follow-up |
13 | questions; |
14 | (iii) Attempting to identify patients' primary care providers and assisting with scheduling |
15 | post-hospital follow-up appointments prior to patient discharge; |
16 | (iv) Expanding the transmission of the department of health's continuity of care form, or |
17 | successor program, to include primary care providers' receipt of information at patient discharge |
18 | when the primary care provider is identified by the patient; and |
| |
1 | (v) Coordinating and improving communication with outpatient providers. |
2 | (3) The discharge plan and transition process shall also be made include recovery |
3 | planning tools for patients with opioid and other substance use disorders substance use disorders, |
4 | opioid overdoses, and chronic addiction which plan and transition process shall include the |
5 | elements contained in subsections (a)(1) or (a)(2) of this section, as applicable. In addition, such |
6 | discharge plan and transition process shall also include: |
7 | (i) Assistance, with patient consent, in securing at least one follow-up appointment for |
8 | the patient within seven (7) days of discharge, as clinically appropriate: |
9 | (A) With a facility licensed by the department of behavioral healthcare, developmental |
10 | disabilities and hospitals to provide treatment of substance use disorders, opioid overdoses, and |
11 | chronic addiction; |
12 | (B) With a certified recovery coach; |
13 | (C) With a licensed clinician with expertise in the treatment of substance use disorders, |
14 | opioid overdoses, and chronic addiction; or |
15 | (D) With a Rhode Island licensed hospital with a designated program for the treatment of |
16 | substance use disorders, opioid overdoses, and chronic addiction. The patient shall be informed of |
17 | said appointment prior to the patient being discharged from the hospital; |
18 | (ii) In the absence of a scheduled follow-up appointment pursuant to subsection (a)(3)(i), |
19 | every reasonable effort shall be made to contact the patient within thirty (30) days post-discharge |
20 | to provide the patient with a referral and other such assistance as the patient needs to obtain a |
21 | follow-up appointment; and |
22 | (iii) That the patient receives information about the real-time availability of appropriate |
23 | in-patient and out-patient services in Rhode Island. |
24 | (iv) That the patient, or non-patient, presenting to hospitals, health care clinics, urgent |
25 | care centers, and emergency room diversion facilities with indication of a substance use disorder, |
26 | opioid overdose, or chronic addiction, shall receive information about the real-time availability of |
27 | clinically appropriate in-patient and out-patient services for the treatment of substance use |
28 | disorders, opioid overdose, or chronic addiction, including: |
29 | (A) Detoxification; |
30 | (B) Stabilization; |
31 | (C) Medication-assisted treatment or medication-assisted maintenance services, including |
32 | methadone, buprenorphine, naltrexone or other clinically appropriate medications; and |
33 | (D) Recovery coaches. |
34 | (4) On or before November 1, 2014 2016, the director of the department of health shall |
| LC004564 - Page 2 of 5 |
1 | develop and disseminate to all hospitals, health care clinics, urgent care centers, and emergency |
2 | room diversion facilities a model discharge plan and transition process for patients with opioid |
3 | and other substance use disorders. This model plan may be used as a guide, but may be amended |
4 | and modified to meet the specific needs of each hospital, health care clinic, urgent care center and |
5 | emergency room diversion facility. with the director of the department of behavioral healthcare, |
6 | developmental disabilities and hospitals shall submit revised regulations for patients presenting to |
7 | hospitals, health care clinics, urgent care centers, and emergency room diversion facilities with |
8 | indication of a substance use disorder, opioid overdose, or chronic addiction to ensure prompt |
9 | access to the clinically appropriate in-patient and out-patient services contained in subsection |
10 | (a)(3)(iv) of this section. The director of the department of health with the director of the |
11 | department of behavioral healthcare, developmental disabilities and hospitals shall develop and |
12 | disseminate to all hospitals, health care clinics, urgent care centers, and emergency room |
13 | diversion facilities model pre-admission, admission and discharge guidelines, a recovery plan and |
14 | transition process for patients with substance use disorders, opioid overdose, or chronic addiction, |
15 | presenting information on the real-time availability of appropriate in-patient and out-patient |
16 | services contained in subsection (a)(3)(iv) of this section. Recommendations from the Rhode |
17 | Island governor’s overdose prevention and intervention task force strategic plan may be |
18 | incorporated into the model plan as a guide, but may be amended and modified to meet the |
19 | specific needs of each hospital, health care clinic, urgent care center and emergency room |
20 | diversion facility. |
21 | SECTION 2. Section 27-38.2-1 of the General Laws in Chapter 27-38.2 entitled |
22 | "Insurance Coverage for Mental Illness and Substance Abuse" is hereby amended to read as |
23 | follows: |
24 | 27-38.2-1. Coverage for the treatment of mental health and substance use disorders. |
25 | -- (a) A group health plan and an individual or group health insurance plan shall provide coverage |
26 | for the treatment of mental health and substance-use disorders under the same terms and |
27 | conditions as that coverage is provided for other illnesses and diseases. |
28 | (b) Coverage for the treatment of mental health and substance-use disorders shall not |
29 | impose any annual or lifetime dollar limitation. |
30 | (c) Financial requirements and quantitative treatment limitations on coverage for the |
31 | treatment of mental health and substance-use disorders shall be no more restrictive than the |
32 | predominant financial requirements applied to substantially all coverage for medical conditions in |
33 | each treatment classification. |
34 | (d) Coverage shall not impose non-quantitative treatment limitations for the treatment of |
| LC004564 - Page 3 of 5 |
1 | mental health and substance-use disorders unless the processes, strategies, evidentiary standards, |
2 | or other factors used in applying the non-quantitative treatment limitation, as written and in |
3 | operation, are comparable to, and are applied no more stringently than, the processes, strategies, |
4 | evidentiary standards, or other factors used in applying the limitation with respect to |
5 | medical/surgical benefits in the classification. |
6 | (e) The following classifications shall be used to apply the coverage requirements of this |
7 | chapter: (1) Inpatient, in-network; (2) Inpatient, out-of-network; (3) Outpatient, in-network; (4) |
8 | Outpatient, out-of-network; (5) Emergency care; and (6) Prescription drugs. |
9 | (f) Medication-assisted therapy treatment or medication-assisted maintenance services of |
10 | substance use disorders, opioid overdoses, and chronic addiction, including methadone, |
11 | buprenorphine, naltrexone or other clinically appropriate medications, maintenance services, for |
12 | the treatment of substance-use disorders, opioid overdoses, and chronic addiction is included |
13 | within the appropriate classification based on the site of the service. |
14 | (g) Payors shall rely upon the criteria of the American Society of Addiction Medicine |
15 | when developing coverage for levels of care for substance-use disorder treatment. |
16 | SECTION 3. This act shall take effect upon passage. |
======== | |
LC004564 | |
======== | |
| LC004564 - Page 4 of 5 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO HEALTH AND SAFETY -- INSURANCE--MENTAL ILLNESS AND | |
SUBSTANCE ABUSE | |
*** | |
1 | This act would require comprehensive discharge planning for patients treated for |
2 | substance use disorders and would require insurers to cover medication-assisted addiction |
3 | treatment including methadone, buprenorphine, and naltrexone. |
4 | This act would take effect upon passage. |
======== | |
LC004564 | |
======== | |
| LC004564 - Page 5 of 5 |